Abstract
Tryptophan oxidation occurs via both extra-hepatic and hepatic pathways. Although these pathways share many enzymes, the first and rate-limiting step in each pathway is carried out by two different enzymes: Indoleamine-Pyrrole 2,3 Dioxygenase (INDO) and Tryptophan 2,3-Dioxygenase (TDO2). Over the course of the last forty years extensive and detailed research by many groups have led to an understanding of some of the important biologic functions of these pathways and their metabolic products. One of the tasks that now lie ahead is linking variations in these genes with variable human responses in different disease states. This short review will focus on known aspects of the INDO and TDO2 gene structure and variability. In addition to INDO and TDO2 a third related gene, the Indoleamine- Pyrrole 2,3 Dioxygenase-like 1 (INDOL1) gene will be discussed. INDOL1 is a gene of unknown function that lies adjacent to INDO on chromosome 8.
Keywords: Indoleamine 2,3-Dioxygenase (INDO), Tryptophan 2,3-Dioxygenase (TDO2), Indoleamine-Pyrrole 2,3 Dioxygenase-like 1 (INDOL1), tryptophan oxidation, gene, single nucleotide polymorphism
Current Drug Metabolism
Title: The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes
Volume: 8 Issue: 3
Author(s): Michael F. Murray
Affiliation:
Keywords: Indoleamine 2,3-Dioxygenase (INDO), Tryptophan 2,3-Dioxygenase (TDO2), Indoleamine-Pyrrole 2,3 Dioxygenase-like 1 (INDOL1), tryptophan oxidation, gene, single nucleotide polymorphism
Abstract: Tryptophan oxidation occurs via both extra-hepatic and hepatic pathways. Although these pathways share many enzymes, the first and rate-limiting step in each pathway is carried out by two different enzymes: Indoleamine-Pyrrole 2,3 Dioxygenase (INDO) and Tryptophan 2,3-Dioxygenase (TDO2). Over the course of the last forty years extensive and detailed research by many groups have led to an understanding of some of the important biologic functions of these pathways and their metabolic products. One of the tasks that now lie ahead is linking variations in these genes with variable human responses in different disease states. This short review will focus on known aspects of the INDO and TDO2 gene structure and variability. In addition to INDO and TDO2 a third related gene, the Indoleamine- Pyrrole 2,3 Dioxygenase-like 1 (INDOL1) gene will be discussed. INDOL1 is a gene of unknown function that lies adjacent to INDO on chromosome 8.
Export Options
About this article
Cite this article as:
Murray F. Michael, The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes, Current Drug Metabolism 2007; 8 (3) . https://dx.doi.org/10.2174/138920007780362509
DOI https://dx.doi.org/10.2174/138920007780362509 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies
and Recent Case Studies
Current Molecular Pharmacology Development of WT1 Peptide Cancer Vaccine Against Hematopoietic Malignancies and Solid Cancers
Current Medicinal Chemistry LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Bladder Injury During Cesarean Delivery
Current Women`s Health Reviews BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets A Review on Recent Developments in Positron Emission Tomography Technology
Recent Patents on Medical Imaging Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry Novel Classes of Dimer Antitumour Drug Candidates
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Drug Targets The Development of Pro-Apoptotic Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Noble metal-dithiocarbamates precious allies in the fight against cancer
Mini-Reviews in Medicinal Chemistry Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke
Current Medicinal Chemistry Methylglyoxal and Advanced Glycation Endproducts: New Therapeutic Horizons?
Recent Patents on Cardiovascular Drug Discovery Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase
Current Pharmaceutical Design Clinical Management of Infectious Diarrhea
Reviews on Recent Clinical Trials Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation
Current Clinical Pharmacology Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer
Current Cancer Drug Targets Antioxidant Effects of Natural Bioactive Compounds
Current Pharmaceutical Design